# Advisor Review - Advisor 2/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-25T19:10:29.377580
**Response ID:** resp_008d5471582ee1260069765b793e0081a385314809726b5f12
**Tokens:** 12839 in / 12177 out
**Response SHA256:** 04723e8e9c9d87c4

---

No fatal errors detected in the categories you specified.

- **Data–design alignment:** Treatment years and “first NAEP exposure” are within the NAEP outcome window (2003–2022). States with no possible post-treatment NAEP in-sample (2022 adopters) are consistently handled as **not treated within the sample** (effectively \(G=\infty\)), and Texas is correctly excluded as always-treated (no pre-period).
- **Post-treatment observations:** Every treated cohort used for ATT estimation has at least one post-treatment NAEP observation under your corrected timing rule; cohorts without any post are not used as treated.
- **Regression sanity:** No obviously broken outputs (no implausibly enormous coefficients/SEs, no impossible CI entries, no NA/Inf/NaN values shown).
- **Completeness:** Tables/figures referenced in the provided excerpt appear to exist and include key statistics (ATT, SE/CI, N). No placeholders (TBD/XXX/etc.) appear.
- **Internal consistency:** Key headline numbers (main ATT and SE) are consistent across text and Table 3; sample-size arithmetic in Table 2 is internally coherent.

ADVISOR VERDICT: PASS